Thymus-derived cells of the mouse, rat, and human can be divided, on the basis of differential expression of cell surface antigens, into phenotypically distinct subsets, and this phenotypic heterogeneity is correlated with functional differences (1-3). In the rat, the monoclonal antibody W3/25 (5) has been shown to label the T subset that contains helper cells for B cells (5) and cytotoxic T cells (6, 7) and also cells that mediate graft-versus-host (GvH) 1 reactivity (5). The monoclonal antibody MRC OX-8 labels the subset that contains suppressor and cytotoxic activities (2, 6, 8) .
A~tibodies
MRC OX-22 monoclonal antibody was derived by a fusion of spleen cells from a BALB/c mouse immunized with phytohemagglutinin-activated rat lymph node cells with NS 1 myeloma cells. Rat lymph node cells were cultured in 10 gg/ml phytohemagglutinin type V from Phaseotus vulgaris (Sigma Chemical Co., Detroit, MI) in RPMI 1640 medium plus 5% DA rat serum, 2.5 x 10 -5 M merca~toethanol and 2 mM glutamine for 3 d. BALB/c mice were immunized twice with 10 blast cells per mouse intraperitoneally at an interval of 10 d, and 6 wk later were immunized again with blast cells intravenously. 3 d later the spleen cells were fused with the NS 1/1.Ag4.1 cell line and hybrids selected according to the procedures of Galfre and Milstein (9) . Cultures with hybrid cells were screened for antibody with the indirect binding assay on blast cells, and clones were obtained from positive cultures by dilution cloning with rat thymocytes as feeders. The positive cultures were recloned at intervals and after growing in mice as ascites. MRC OX-22 was found to be of lgG~ class by formation of precipitin in agar using rabbit antimouse IgGl antiserum, kindly provided by M. Parkhouse and rabbit anti-mouse IgGz~ and IgG2b serum from Miles Laboratories Ltd. Other mouse monoclonai anti-rat cell antibodies used were: W3/13 and W3/25 (4); MRC OX-7 (10); MRC OX-8 (2); MRC OX-12 (11) , and MRC OX-19 (6) . Rabbit anti-mouse (RAM) F(ab')2 and its fluorescein isothiocyanate (FITC) conjugate (RAM-FITC) were prepared as described previously (4) . Rat anti-rat 1 a allotype was as described in (11) and rabbit anti-rat F(ab')2 as in (12) . Antibodies were labeled with '25I by the chloramine T method to a specific activity of ~25 uCi/ug (10) .
Media
Cells were suspended in Dulbecco's A + B medium (DAB), with either 2% newborn calf serum (NCS) or 0.2% bovine serum albumin (BSA). 10 mM sodium azide was added to cells for fluorescence-activated cell sorter (FACS) (B-D FACS Systems, Sunnyvale, CA) analysis and sorting.
Cells
Thoracic duct lymphocytes (TDL) were collected overnight into DAB containing 20 IU/ml heparin at 4°C. Spleen cells were obtained by pressing spleens through a wire gauze into ice-cold DAB/NCS, and after washing, erythrocytes and dead cells were removed by suspending the cells in 5 ml distilled water for 5 s after which isotonicity was restored by the addition of 5 ml 1.8% NaCI. The dead cells were clumped and filtered on a small cotton wool plug and red cell ghosts were removed by washing cells twice by centrifugation.
Cell Separation by Rosetting
T cells or B cells were isolated from rat TDL or splenocytes by depletion of cells that rosetted with sheep erythrocytes coated with anti-rat Ig or W3/13 antibody, as described by Mason (13) .
Cell Sorting Using a FACS H
2.5 x 108 lymphocytes were incubated with the appropriate monoclonal antibody for 1 h at 4°C, washed twice in DAB/NCS, and then incubated with RAM-FITC for 1 h also at 4°C. After a final wash they were suspended in 15 ml DAB/NCS/azide. Red and dead cells were excluded by the appropriate scatter gating.
Assays
GvH Assa~,s. The popliteal lymph node assay was used exactly as described by Ford et al. (14) . Lethal GvH disease was induced by the protocol described in (13) . Details of cell doses for these assays are given in the main text.
Helper Cell Assay. An adoptive transfer method was used in which sorted lymphocytes from animals primed with dinitrophenyl-bovine gamma globulin (DNP-BGG) were injected intravenously together with 1 mg of DNP-BGG into irradiated syngeneic recipients (700 rad) (5). Serum was collected 7 d later and assayed for anti-DNP antibody.
Binding Assay for Anti-DNP Antibody. Rat sera were diluted in DAB/2% NCS and 50-/~1 aliquots were assayed in triplicate at 4°C for binding to DNP-BGG adsorbed to wells of 96-well polyvinyl chloride Linbro plates (Linbro Chemical Co., Hamden, CT). Bound antibody was detected by a second incubation with 50 ttl of ~5I-rabbit anti-rat F(ab')2 antibody with sera from PVG/c donors or ~5I-rat anti-rat 1 a allotype antibody for sera from PVG-1 a donors. To prepare the plates 50 #1 per well of DNP29-BGG at 200 #g/ml in DAB/0.2% NCS was left in the wells overnight followed by washing with water, incubation for 1 h with 10% rabbit or human serum in DAB/10 mM NAN3, and washing again with water. In the assays both incubations were for 1 h with 3 washes with DAB/ 0.2% NCS after each step. Finally, the plates were air-dried, the wells were cut off with a hot wire, and ~5I was counted with an LKB Rackgamma counter (LKB Instruments, Inc., Rockville, MD). (15) . MRC OX-22 ascites fluid was diluted 1:25,000 and aliquots were incubated at 4°C for 2 h with various dilutions of cell suspensions of spleen, thymus, and erythrocytes, or homogenates of kidney and liver. The erythrocytes and kidneys were derived from animals irradiated 3 d before with 950 rad to remove lymphocytes. Then the mixtures were centrifuged and the supernatants assayed for residual antibody by the indirect binding assay using trace conditions (15, 16) .
Quantitative Absorption Assays with Cells and Tissue Homogenates

Localization of Antigens in Cryostat Sections
Cryostat sections of rat brain, spleen, kidney, skin, and thymus were stained for cells reactive with monoclonal antibodies MRC OX-22, MRC OX-18 (mouse anti-rat class 1 major histocompatibility complex (MHC) antibody [17] ) and MRC OX-21 (mouse antihuman C3b inactivator antibody [ 18] ) using the immunoperoxidase method described by Barclay (19) . The peroxidase-conjugated rabbit Fab anti-mouse Ig reagent was the kind gift of Dr. A. N. Barclay (19) .
Biochemical Analysis
For analysis of surface-labeled glycoproteins, TDL were labeled with [3H]borohydride after oxidation with periodic acid (20, 21) , solubilized, and subjected to affinity chromatography exactly as in (22) except that 1 mM phenylmethylsulfonyl fluoride (PMSF) was used as a proteolytic inhibitor rather than diisopropylfluorophosphate (DFP). Samples were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with radiolabeled material visualized by fluorography, as described in (22) .
Results
Tissue Distribution of Cells Binding MRC 0X-22 Monoclonal Antibody
Flow Cytofluorograph Analysis. Cells were incubated with MRC OX-22 monoclonal antibody followed by fluorescein-conjugated rabbit F(ab')~ anti-mouse Ig antibodies, and binding was analyzed by flow cytofluorography. As shown in Table I and Fig. 1 , a total of 84% of cells were labeled and the fluorescence histogram showed three populations, one unlabeled, one weakly positive, and one strongly so. TDL were incubated with MRC OX-22 antibody along with other mouse anti-rat monoclonal antibodies to T subsets and the results are presented in Table I and were used to construct the subpopulation diagram in effect (data not shown). The pattern of labeling on spleen cells was essentially identical to that of TDL but only 2.1% of thymocytes were labeled by MRC OX-22 antibody (Fig. 1) . Analysis of bone marrow revealed a bimodal profile with 46% of cells labeled ( Fig. 1 , Table I ). ¾ of these cells were unlabeled by W3/13 monoclonal antibody, which labels marrow polymorphs (4) and hemopoietic stem cells (23) most marrow lymphocytes. In contrast, all of the MRC OX-22 + cells were also labeled by MRC OX-7 antibody (Thy-1 +), which labels stem cells and the marrow lymphocytes that are thought to be immature B cells (24) . It thus seems likely that MRC OX-22 antibody labels most cells of the B lineage in the marrow as well as in the periphery.
Detectio~ of MRC 0X-22 + Cells on Cryostat Sections.
Immunoperoxidase staining of cryostat sections of spleen revealed a reaction pattern that was consistent with that obtained by flow cytofluorography in that, although both B and T cells were labeled, the staining of the B areas was more intense than that of the T areas. The staining pattern in the thymus was unique in that, though few cells were stained, the majority of these positive cells were found at the edge of the medulla, which was defined by staining with MRC OX-18 antibody (Fig. 3) . Additionally, there were labeled cells scattered through the cortex with an apparently random distribution. Staining of sections of liver, brain, and skin failed to detect any antigen present, while in the kidney very faint staining was seen only in the glomeruli (the significance of this latter finding is doubtful).
Quantitative Absorption Analysis. Rat erythrocytes, splenocytes, thymocytes, and homogenates of kidney and liver were used to absorb MRC OX-22 antibody, and the completeness of absorption was determined by assaying the residual antibody on TDL using a cellular radioimmunoassay. Thymocytes had 2.3% of the absorptive capacity of spleen cells, but erythrocytes, kidney, and liver failed to produce any absorption even when weights of wet tissue were used that were 100 times that of the amount of spleen needed to give complete absorption of the antibody. Thus the absorption data is fully consistent with the results for antigen distribution by FACS analysis and from the staining of cryostat sections. 
Biochemical Characterization of the MRC 0X-22 Antigen
The sialic acid of glycoproteins of TDL was labeled with 3H by reduction with [SH]Na borohydride after oxidation with periodic acid (20) . Membrane molecules were solubilized in 1% Nonidet P-40 (NP-40) detergent and the extract was passed through an MRC OX-22 antibody affinity column. A glycoprotein of 220,000 apparent mol wt was eluted from the column (Fig. 4) . The binding of this glycoprotein was specific since this band was not retained on control columns (data not shown). The 220,000 tool wt glycoprotein also binds to an affinity column containing MRC OX-1 antibody specific for L-CA (Fig. 4) . Bands at 200,000, 190,000, and 180,000 tool wt also bind to the MRC OX-1 column. These lower tool wt bands are thought to be derived from T cells (25) , and in Fig. 4 it is clear that the 190,000 and 180,000 mol wt bands do not bind to the MRC OX-22 column. However, the 200,000 mol wt band does appear to bind at least in part to MRC OX-22 antibody; whether this might be the T cell form of the MRC OX-22 antigen remains to be established. Also there appeared to be some bands of "~220,000 tool wt that were bound by the MRC OX-1 but not the MRC OX-22 column, and the origin of these also requires further investi-FIGURE 4. SDS-PAGE of SH-labeled glycoproteins purified on MRC OX-22 or MRC OX-1 affinity columns. 9 x 108 TDL were oxidized with periodate and reduced with 10 mCi NaB[nil]4. The membrane proteins were solubilized in 6 ml 1% NP-40 and after centrifugation aliquots of the extract were passed through MRC OX-22 and MRC OX-1 affinity columns (5 ml with 10 mg IgG/ml Sepharose 4B). The columns were washed with 0.5% deoxycholate in 10 mM Tris HCI, pH 8, and bound material was then eluted with the same buffer plus 0.05 M diethylamine HC1, p H I 1.5. The gels show electrophoresis of trichloroacetic acid-precipitable material from starting extract (unfractionated), extract passing through the column (passed), and eluted materials (eluted). The unfractionated and passed tracks used material derived from 75 t*l of starting extract, whereas the eluted tracks used material from 150 #l of starting extract.
gation.
The clear point from Fig. 4 is that MRC OX-22 antibody reacts mainly with the high tool wt form of the L-CA. Proof that the MRC OX-22 glycoprotein is part of the L-CA complex is given in Table II , which shows the counts per minute of 3H-labeled glycoproteins eluted from MRC OX-1 and MRC 0X-22 columns run in series. When the MRC OX-1 column preceded the MRC OX-22 column, almost no cpm were eluted from the second column, whereas when the MRC OX-22 column was first, it bound ~2 0 % of the radioactive material that can be bound by the MRC OX-1 column.
Functional Studies
Previous studies have shown that cells which mediate helper functions for B cell responses and the GvH reaction as measured by the popliteai lymph node assay are found exclusively in a T cell subset that is uniformly labeled by W 3 / 25 antibody. Labeling with MRC OX-22 antibody subdivides the W 3 / 2 5 + cells (Fig. 1) and functional studies were carried out to see whether this subdivision correlated with different functional activities.
GvH Reactivity and GvH Disease. The results in Fig. 5 shows that the cells which mediate popliteal lymph node enlargement are all labeled by MRC OX-22 antibody and that the unlabeled cells do not show this activity. This is true whether the sorted cells were injected in doses proportional to the frequency of MRC OX-22-and MRC OX-22 + cells in the original parental TDL (physiological doses) or if cell doses were adjusted so as to give all recipients equal numbers of T cells (equal T cell doses).
In contrast to GvH reactivity as demonstrated by the popliteal lymph node (Fig. 2 ) the synergy observed in the experiment described in Table III suggested that the B memory cells were in the MRC OX-22 + fraction and helper T cells for B cell responses in the MRC OX-22-one. To test this conclusion directly MRC OX-22-and MRC OX-22 ÷ cells, from primed donors, were supplemented with primed B cells, and the ability of these mixtures to adoptively transfer secondary antihapten responses was assayed. The results, presented in Table III (experiment 2), showed that the MRC OX-22-cells were much more active in providing B cell help than were the MRC OX-22 + cells. However, the MRC OX-22 + cells appeared to provide some help and the reconstitution with MRC OX-22-cells was not complete compared with the response obtained from unfractionated TDL. This result was obtained from three similar experiments. Further comments on this result are deferred to the Discussion.
Cells Mediating Allogeneic Suppression of Antibody Synthesis are MRC 0X-22 +. Under appropriate conditions the induction of GvH disease in F~ rats is
accompanied by a profound suppression of antibody synthesis (2, 5) . This allogeneic suppression is mediated by MRC OX-8 ÷ cells (2) , which form --, 10% of all cells in TDL. Because the percentage of these cells is so small, it is not Table I that all MRC OX-8 + cells are also MRC OX-22 ÷. To verify that the cells responsible for allogeneic suppression were MRC OX-22 +, sublethally irradiated Fa rats were given haptencarrier-primed F~ spleen cells and either unfractionated, primed parental TDL or parental TDL that had been fractionated on the FACS into MRC OX-22-and MRC OX-22 + subsets. The allogeneic suppressive activity of the parental spleen cells was wholly contained within the MRC OX-22 + population (Table  IV) . This experiment was repeated with the same result.
Phenotype of the Memory B Cell. Memory B cells in rat TDL constitute only a few percent of all the cells present (26) , so although the population analysis shown in Table I indicated that the great majority of all B cells in TDL were MRC OX-22 +, this did not conclusively demonstrate that the memory B cell also expressed this antigen. Further, the small but significant antibody response observed (Table III) when MRC OX-22-cells were transferred into sublethally irradiated hosts was of uncertain origin, since, in principle, the T helper cells in the population could have been collaborating with any donor B cells present in the MRC OX-22-inoculum or with radio-resistant B cells in the host (27) . To determine directly whether any B memory cells were MRC OX-22-, an adoptive transfer experiment was carried out using hapten-carrier-primed TDL from l a ligbt chain allotype donors and sublethally irradiated congenic recipients of the 1 b allotype (11) . To ensure that T helper cells were not limiting in the assay, all recipients of MRC OX-22-cells and MRC OX-22 ÷ ceils also received hapten- carrier-primed T helper cells from 1 a allotype donors. The solid phase radioimmunoassay was made specific for antihapten antibody of donor allotype by using 125I-iabeled anti-1 a allotype antibody. As Fig. 7 shows, the MRC OX-22 + cells, when provided with T cell help, provided a response equal to that of unfractionated TDL, while the MRC OX-22-population was completely inactive. A second experiment gave the same result.
Discussion The principal findings of this work are that the MRC OX-22 monoclonal antibody recognizes the high molecular weight form of the rat L-CA and defines a new functional subset of T cells. In rat (25) , mouse (28) , and man (29) , the molecular weight of L-CA varies in a similar manner according to the cell type from which it is extracted. In the rat, the predominant forms of the L-CA from thymocytes, T cells, and B cells run on SDS-PAGE with apparent molecular weight of 170,000, 190,000 (multiple bands), and 220,000 respectively (25) . These different forms have different carbohydrate structures, as shown by the differences in binding of peanut and soybean lectin but it is possible that the protein is identical for the different types. In the present analysis on glycoproteins from mixtures of T and B cells, MRC OX-22 antibody was seen to bind mainly to the high molecular weight form of L-CA, which was previously thought to be characteristic of B cells. However, MRC OX-22 antibody labels 2A of T cells at low levels in addition to its heavy labeling of B cells, and this suggests that either T cells express the high molecular weight form of L-CA as well as the dominant bands around 190,000 tool wt, or that a minor band at 200,000 mol wt, which also appeared to bind to MRC OX-22 antibody, is the T cell product. Obviously more work on the molecular weight heterogeneity of T cell L-CA is needed as is analysis of the protein or carbohydrate nature of the antigenic variation.
Comparison of the MRC OX-22 data with the results of Dalchau and Fabre (30, 31) show that rat and human L-CA have similar patterns of antigenic heterogeneity. Dalchau and Fabre described a monoclonal antibody that reacts with the high molecular weight form of L-CA and labels all B cells, all T cells of the cytotoxic/suppressor phenotype (OKT8 ÷ cells), l/s of T helper cells (OKT4 + cells), and a small percentage of thymocytes (30, 31) . Apart from the fact that this antibody labels only ½ of the OKT4 + cells in man, whereas MRC OX-22 labels 2/3 of W3/25 + cells in the rat, these tissue distributions are identical. In the mouse, the 2C2, 14D10, and 14.8 monoclonal antibodies all recognize the high molecular weight form of the L-CA and are expressed on Lyt-2 ÷ cells (32) (33) (34) . However, except in the lpr mouse, the antigen recognized by those antibodies is not expressed on Lyt-2-cells that seem to be the homologue of rat W3/25 + cells.
The experiments on the fractions of the MRC OX-22-and MRC OX-22 + subsets of rat TDL revealed a hitherto unknown heterogeneity in the T cell subset that expresses the W3/25 antigen. This is seen in the correlation between rat T cell subsets and functions summarized in Table V. As the table shows (Table III) . In man and mouse, monoclonal antibodies have been described that label B cells and subsets of T cells (31) (32) (33) (34) 36) . With the exception of the monoclonal antibody TQ1, described by Reinherz et al. (36) , and the monoclonal antibody of Dalchau and Fabre (31) , none of these antibodies appears to divide the T helper subset and functional studies have been made only with TQ1. The T4+TQ1 -T cell subset in man shows similarity with the W3/25 +, MRC OX-22-population in the rat in that both provide help for B cells but, as with W3/ 25 ÷, MRC OX-22 + cells, the T4÷TQ1 + subset showed some weak helper activity. No biochemical characterization of the TQ1 antigen has been made and the homology between the subsets of T helper cells in the two species is not yet firmly established.
The observation that although most peripheral T ceils were MRC OX-22 +, most thymocytes were not labeled by this antibody suggests that the few MRC OX-22 + cells in the thymus were mature cells. "~50% of these cells were found at the edge of the medulla where thymocytes are believed to leave the thymus (37), but because small numbers of peripheral T cells migrate back to the thymus medulla (38) , it cannot be ruled out that these MRC OX-22 + cells are T cells entering the thymus rather than mature thymocytes leaving it. The MRC OX-22 + cells in the thymic cortex made up the remaining 50% of cells with this phenotype. These cells are unlikely to be of peripheral T cell origin (38) and their presence raises the possibility that, rather than involving an intramedullary phase, thymocyte maturation may go on to completion within the thymic cortex. Clearly it would be of value to know if these cells express both the W3/25 and MRC OX-8 antigens, as do the great majority of rat cortical thymocytes (17) , or whether they express only one or another of these markers, as do most mature T cells.
The MRC OX-22 antibody is potentially of value in the isolation of the rat bone marrow stem cell. As Table I shows, almost all Thy-1 + bone marrow cells also express the MRC OX-22 antigen and it is known that rat stem ceils are to be found amongst the Thy-1 + population (24) . If it turns out that stem cells are MRC OX-22-, then the isolation of Thy-1 ÷, MRC OX-22-cells will provide a highly enriched source of these cells. Summary A mouse monoclonal antibody (MRC OX-22) is described that labels rat T cells which mediate graft-versus-host reactions and those responsible for the suppression of antibody synthesis in hosts undergoing these reactions. In contrast, most of the T cells that provide help for B cells are MRC OX-22 negative. These results, taken together with those published previously, demonstrate that the rat contains at least three phenotypically and functionally distinct subsets of T cells. The MRC OX-22 antibody also labels all B cells, 50% of bone marrow cells, but only 2% of thymocytes. Of these latter cells about half are found at the edge of the medulla and the remainder are randomly distributed throughout the cortex and medulla. These findings lend support to the view that mature thymocytes leave the thymus at the cortico-medullary junction, and also suggest that both cortex and medulla may be sites where thymocytes mature. Biochemical studies showed that the MRC OX-22 antibody reacts with the high molecular weight form of the leukocyte-common antigen (L-CA). Comparison with data on human L-CA suggests that the molecular and antigenic heterogeneity of this set of glycoproteins has been conserved between rat and man.
